Analysts recommend trimming ~30% of MDLZ exposure at $62.50 to preserve capital given that consensus has priced in a ~75% EPS rebound at 18.6x forward earnings (requiring five positive outcomes), while MACD histogram decayed 72% in eight sessions and volume collapsed from 20M to 5M. Retain a core defensive position for beta 0.40 protection and the 3.19% dividend, with stops at $58.20 and re-entry triggers at $58.20 on confirmed support with MACD expansion or above $66.65 on volume ≥15M with MACD histogram re-expanding.